A future free of cancer requires a fundamental shift in thinking: cancer patients can no longer be treated as a homogeneous group. BC Cancer has established itself as a global leader in precision medicine and is poised to revolutionize the future of cancer care.
- Personalized onco-genomics, or POG, is changing the way cancer is diagnosed and treated, proving that genomics can change the way we treat cancer. It’s one of the most exciting cancer research initiatives ever undertaken in BC, and is setting a global precedent, in terms of the diversity of cancers investigated and the number of patients participating. POG has taught us that we aren’t limited to traditional anti-cancer drugs and is fundamentally shifting how cancer medicine is practiced.
- PanGen is an innovative initiative that for the first time in BC is using genomics to identify different types of pancreatic cancer. The PanGen team hopes to identify unique biomarkers that will result in more effective treatments for patients facing this deadly form of cancer. There is strong interest internationally in this novel research, with the opportunity to improve the diagnosis and treatment of pancreatic cancer worldwide.
- A world first: machine-learning software was used to analyze data from single cancer cells, allowing BC Cancer researchers to map the spread of the deadliest ovarian cancer. This innovative approach will be used to more closely examine cells that become resistant to treatment, and promises to be further engineered into a predictive tool.
- BC Cancer is the first in Canada to launch a province-wide personalized medicine panel test through standard of care; the oncopanel, myeloid panel, and hereditary panels are informing thousands of patient treatment plans. These genomic-based tests can be updated every six months, informed by clinically actionable targets discovered through programs such as POG.
- At the forefront of personalized medicine, the Centre for Lymphoid Cancer is leading the development of new genomic based prognostic tests to reduce treatment failure and improve patient survival.
- In a national first, BC Cancer, Terry Fox Research Institute and Princess Margaret Cancer Centre launched an innovative pilot project to accelerate precision medicine for cancer patients. The pilot will provide much-needed evidence on how best to roll out a broader vision for data sharing and collaborative translational and clinical research to enable precision medicine for the cancer population.